Compile Data Set for Download or QSAR
Report error Found 279 Enz. Inhib. hit(s) with Target = 'Lymphokine-activated killer T-cell-originated protein kinase'
TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM148993(US8962648, 73 | US8962648, 72)
Affinity DataIC50: 0.380nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149054(US8962648, 319)
Affinity DataIC50: 0.430nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149042(US8962648, 276)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM50520955(CHEMBL4445123)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human TOPK using MBP as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding methodMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149041(US8962648, 275)
Affinity DataIC50: 0.540nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149027(US8962648, 235)
Affinity DataIC50: 0.570nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM148993(US8962648, 73 | US8962648, 72)
Affinity DataIC50: 0.630nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149118(US8962648, 1160)
Affinity DataIC50: 0.640nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149043(US8962648, 277)
Affinity DataIC50: 0.670nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149016(US8962648, 195)
Affinity DataIC50: 0.730nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149039(US8962648, 273)
Affinity DataIC50: 0.740nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149192(US8962648, 1309)
Affinity DataIC50: 0.740nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM148997(US8962648, 84)
Affinity DataIC50: 0.780nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149034(US8962648, 266)
Affinity DataIC50: 0.780nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149026(US8962648, 233)
Affinity DataIC50: 0.810nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149062(US8962648, 336)
Affinity DataIC50: 0.820nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149038(US8962648, 272)
Affinity DataIC50: 0.880nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149097(US8962648, 1120)
Affinity DataIC50: 0.880nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149010(US8962648, 187)
Affinity DataIC50: 0.900nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149074(US8962648, 359)
Affinity DataIC50: 0.920nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149044(US8962648, 278)
Affinity DataIC50: 0.970nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149169(US8962648, 1271)
Affinity DataIC50: 1nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149007(US8962648, 176 | US8962648, 175)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149087(US8962648, 1082)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149007(US8962648, 176 | US8962648, 175)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149067(US8962648, 345)
Affinity DataIC50: 1.20nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149081(US8962648, 1052)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149091(US8962648, 1095)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149094(US8962648, 1111)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149104(US8962648, 1131)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149112(US8962648, 1148)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149121(US8962648, 1163)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149131(US8962648, 1187)
Affinity DataIC50: 1.30nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149102(US8962648, 1127)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149159(US8962648, 1252)
Affinity DataIC50: 1.40nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149127(US8962648, 1174)
Affinity DataIC50: 1.5nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149012(US8962648, 192 | US8962648, 191)
Affinity DataIC50: 1.60nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM50520970(CHEMBL4452726)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of human TOPK using MBP as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding methodMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149185(US8962648, 1300)
Affinity DataIC50: 1.70nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM148992(US8962648, 65)
Affinity DataIC50: 1.80nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149140(US8962648, 1209)
Affinity DataIC50: 1.80nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149012(US8962648, 192 | US8962648, 191)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149056(US8962648, 327)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149065(US8962648, 339)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149070(US8962648, 348)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149071(US8962648, 349)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149035(US8962648, 267)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149052(US8962648, 313)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149014(US8962648, 347 | US8962648, 193)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetLymphokine-activated killer T-cell-originated protein kinase(Human)
Oncotherapy Science

US Patent
LigandPNGBDBM149072(US8962648, 353)
Affinity DataIC50: 2nMpH: 7.4 T: 2°CAssay Description:PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a s...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 279 total ) | Next | Last >>
Jump to: